Regeneron Pharmaceuticals shares owned by Lipe & Dalton
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Lipe & Dalton
from 13F filings
Historical chart of Lipe & Dalton investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Lipe & Dalton consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Lipe & Dalton
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $236k | 269 | 877.32 |
| 2023-09-30 | $221k | 269 | 821.56 |
| 2023-06-30 | $193k | 269 | 717.47 |
| 2023-03-31 | $237k | 289 | 820.07 |
| 2022-12-31 | $209k | 289 | 723.18 |
| 2022-09-30 | $213k | 309 | 689.32 |
| 2022-06-30 | $183k | 309 | 592.23 |
| 2022-03-31 | $216k | 309 | 699.03 |
| 2021-12-31 | $195k | 309 | 631.07 |
| 2021-09-30 | $126k | 209 | 602.87 |
| 2021-06-30 | $117k | 209 | 559.81 |
| 2019-12-31 | $478k | 1.3k | 375.20 |
| 2019-09-30 | $326k | 1.2k | 277.68 |
| 2019-06-30 | $302k | 964 | 313.28 |
| 2019-03-31 | $338k | 824 | 410.19 |